Researchers have developed and are testing a small, implanted gastric balloon that people can inflate or deflate to feel full ...
State measures now seek to remove barriers to weight-loss drugs, as demand for the meds skyrockets amid rising concerns about ...
Doctors say early obesity intervention can help prevent later health problems. But prescribing GLP-1s, such as Ozempic and ...
Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.
Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% ...
While recent advances in medicine have created prescription anti-obesity GLP-1 medications — like Ozempic, Wegovy, and ...
Most common exclusion criteria were major depressive disorder, malignant neoplasms, liver disease, uncontrolled HTN ...
President Biden plans to roll out a new plan that would require coverage of weight loss drugs for patients of Medicare and ...
The proposal would expand coverage of anti-obesity drugs to 7.5 million people covered by Medicare and Medicaid, the Biden ...
Ozempic, Wegovy, and other weight-loss drugs could make millions healthier, but access and affordability barriers abound.
This may be the first Thanksgiving for millions of Americans who are on GLP-1 agonists like Ozempic, Zepbound or Wegovy.
Dr. Darien Sutton and Dr. Stephanie Widmer discuss new studies, which found GLP-1 weight loss drugs beneficial in fighting Type 2 diabetes and certain addiction disorders. Semaglutide, the active ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback